Gamble Jones Investment Counsel’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $1.22M | Hold |
15,531
| – | – | 0.09% | 100 |
|
|
2022
Q3 | $1.09M | Sell |
15,531
-1,310
| -8% | -$103K | 0.09% | 105 |
|
|
2022
Q2 | $1.35M | Sell |
16,841
-276
| -2% | -$21.6K | 0.1% | 98 |
|
|
2022
Q1 | $1.3M | Buy |
17,117
+26
| +0.2% | +$2.06K | 0.08% | 105 |
|
|
2021
Q4 | $1.46M | Sell |
17,091
-1,700
| -9% | -$133K | 0.09% | 103 |
|
|
2021
Q3 | $1.42M | Hold |
18,791
| – | – | 0.09% | 102 |
|
|
2021
Q2 | $1.53M | Sell |
18,791
-2,076
| -10% | -$170K | 0.1% | 100 |
|
|
2021
Q1 | $1.65M | Sell |
20,867
-1,000
| -5% | -$78.4K | 0.11% | 98 |
|
|
2020
Q4 | $1.87M | Sell |
21,867
-581
| -3% | -$48K | 0.13% | 92 |
|
|
2020
Q3 | $1.73M | Sell |
22,448
-553
| -2% | -$42.2K | 0.13% | 89 |
|
|
2020
Q2 | $1.69M | Sell |
23,001
-100
| -0.4% | -$7.1K | 0.13% | 86 |
|
|
2020
Q1 | $1.53M | Sell |
23,101
-552
| -2% | -$38.9K | 0.14% | 84 |
|
|
2019
Q4 | $1.63M | Sell |
23,653
-1,295
| -5% | -$88.3K | 0.13% | 96 |
|
|
2019
Q3 | $1.83M | Sell |
24,948
-800
| -3% | -$58K | 0.15% | 89 |
|
|
2019
Q2 | $1.84M | Buy |
25,748
+610
| +2% | +$43.3K | 0.16% | 89 |
|
|
2019
Q1 | $1.72M | Sell |
25,138
-275
| -1% | -$17.8K | 0.15% | 92 |
|
|
2018
Q4 | $1.51M | Hold |
25,413
| – | – | 0.15% | 95 |
|
|
2018
Q3 | $1.7M | Sell |
25,413
-300
| -1% | -$20K | 0.16% | 98 |
|
|
2018
Q2 | $1.67M | Sell |
25,713
-244
| -0.9% | -$16K | 0.17% | 99 |
|
|
2018
Q1 | $1.86M | Sell |
25,957
-300
| -1% | -$21.6K | 0.19% | 96 |
|
|
2017
Q4 | $1.98M | Buy |
26,257
+761
| +3% | +$55.6K | 0.19% | 92 |
|
|
2017
Q3 | $1.86M | Buy |
25,496
+31
| +0.1% | +$2.23K | 0.19% | 96 |
|
|
2017
Q2 | $1.89M | Buy |
25,465
+90
| +0.4% | +$6.68K | 0.2% | 95 |
|
|
2017
Q1 | $1.86M | Sell |
25,375
-856
| -3% | -$59.9K | 0.2% | 92 |
|
|
2016
Q4 | $1.72M | Sell |
26,231
-833
| -3% | -$57.1K | 0.19% | 96 |
|
|
2016
Q3 | $2.01M | Buy |
27,064
+29
| +0.1% | +$2.14K | 0.22% | 85 |
|
|
2016
Q2 | $1.98M | Sell |
27,035
-1,310
| -5% | -$93.3K | 0.22% | 85 |
|
|
2016
Q1 | $2M | Sell |
28,345
-370
| -1% | -$24.6K | 0.22% | 80 |
|
|
2015
Q4 | $1.91M | Buy |
28,715
+219
| +0.8% | +$14.6K | 0.21% | 86 |
|
|
2015
Q3 | $1.81M | Buy |
28,496
+24
| +0.1% | +$1.57K | 0.21% | 90 |
|
|
2015
Q2 | $1.86M | Sell |
28,472
-33
| -0.1% | -$2.24K | 0.19% | 92 |
|
|
2015
Q1 | $1.98M | Sell |
28,505
-1,035
| -4% | -$71.5K | 0.21% | 92 |
|
|
2014
Q4 | $2.04M | Sell |
29,540
-404
| -1% | -$27.3K | 0.21% | 84 |
|
|
2014
Q3 | $1.95M | Buy |
29,944
+68
| +0.2% | +$4.49K | 0.22% | 80 |
|
|
2014
Q2 | $2.04M | Sell |
29,876
-624
| -2% | -$41.8K | 0.23% | 78 |
|
|
2014
Q1 | $1.98M | Sell |
30,500
-146
| -0.5% | -$9.2K | 0.23% | 79 |
|
|
2013
Q4 | $2M | Sell |
30,646
-2,482
| -7% | -$159K | 0.24% | 78 |
|
|
2013
Q3 | $1.97M | Sell |
33,128
-387
| -1% | -$22.9K | 0.25% | 70 |
|
|
2013
Q2 | $1.92M | Buy |
+33,515
| New | +$1.99M | 0.25% | 66 |
|
Other funds holding CL
TP
Gamble Jones Investment Counsel's CL Position: Q4 2022 in Review
Gamble Jones Investment Counsel held its Colgate-Palmolive (CL) position steady in Q4 2022 at 15,531 shares worth $1.22M. The position accounts for 0.09% of the portfolio, ranked #100.
Gamble Jones Investment Counsel first reported a position in CL in Q2 2013 and has held it in 39 quarters since. The position peaked at $2.04M in Q4 2014. 1,698 funds tracked by Wall St. Rank hold CL as of Q4 2022.
- Gamble Jones Investment Counsel held 15,531 shares of Colgate-Palmolive worth $1.22M as of Q4 2022.
- Gamble Jones Investment Counsel left its Colgate-Palmolive share count unchanged in Q4 2022.
- Colgate-Palmolive made up 0.09% of Gamble Jones Investment Counsel's portfolio in Q4 2022, its #100 holding.
- Gamble Jones Investment Counsel first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 39 quarters since.
- Gamble Jones Investment Counsel's Colgate-Palmolive position peaked at $2.04M in Q4 2014.
- 1,698 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2022.
Based on Gamble Jones Investment Counsel's 13F filing for Q4 2022, filed 8 Feb 2023.